Loading
Latest filing published 02 Jul 2024 for Cano Health, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David J. Armstrong is a declared insider of Cano Health, Inc. (chief executive), with filings sourced from SEC (Form 4). We count 16 filings; the first trade dates from 18 August 2021 and the latest from 28 June 2024.
Both buying and selling appear: 1 purchase worth €128k, against 1 sale worth €4,067. The net balance comes to €124k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 12 share grants.
The record was last updated on 2 July 2024 with a transaction in Cano Health, Inc. The last purchase on record was published on 24 August 2021, which is 1,887 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations